Status:
RECRUITING
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Lead Sponsor:
University of Latvia
Collaborating Sponsors:
Technion, Israel Institute of Technology
University of Ulm
Conditions:
Gastric Cancer
Atrophic Gastritis
Eligibility:
All Genders
18+ years
Brief Summary
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet,...
Detailed Description
Patients with established disease (gastric cancer, precancerous lesions) as well as patients investigated for the lesions and having been documented lack of the lesions will be enrolled to the study a...
Eligibility Criteria
Inclusion
- Patients with verified gastric cancer (Group 1 \& 2)
- Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
- Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
- Motivation to participate in the study
- Physical status allowing volatile marker sampling and other procedures within the protocol
- Signed consent
Exclusion
- Known other active cancer
- Ventilation problems, airway obstruction
- Unwillingness or inability to co-operate
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04022109
Start Date
November 1 2019
End Date
December 1 2026
Last Update
July 26 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
A.C.Camargo Cancer Center
São Paulo, Brazil
2
Pontificia Universidad Catolica de Chile
Santiago, Chile
3
Centro Javeriano de Oncología, San Ignacio University Hospital
Bogotá, Colombia
4
Institute of Clinical and Preventive Medicine, University of Latvia
Riga, Latvia, LV1050